In Pursuit of Drugs for American Trypanosomiasis: Evaluation of Some "Standards" in a Mouse Model

Experimental Biology and Medicine

Volumn 216, Issue 3, 1997, Pages 424-428

  Kinnamon, Kenneth E ^a,c   Poon, Bing T ^a   Hanson, William L ^b   Waits, Virginia B ^b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID DERIVATIVE; ANTIBIOTIC AGENT; ANTIFILARIAL AGENT; ANTIMALARIAL AGENT; ANTIMONY TARTRATE; ANTISCHISTOSOMAL AGENT; ANTITRYPANOSOMAL AGENT; ARTEMISININ; CAMBENDAZOLE; CLOPIDOL; DIETHYLCARBAMAZINE; DIMINAZENE ACETURATE; ETHIDIUM; FLUBENDAZOLE; HYDROXYSTILBAMIDINE; IMIPRAMINE; KANAMYCIN; KETOCONAZOLE; MENOCTONE; MEPACRINE; NIFURTIMOX; NIGERICIN; NIRIDAZOLE; PENTAMIDINE; PRODIGIOSIN; PROTRIPTYLINE; STIBOCAPTATE; STILBAMIDINE; TIABENDAZOLE; UNINDEXED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROTOZOAL ACTIVITY; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; EXPERIMENTAL MODEL; FEMALE; MOUSE; NONHUMAN; STANDARD;

ANIMALS; ANTIPROTOZOAL AGENTS; CHAGAS DISEASE; DISEASE MODELS, ANIMAL; FEMALE; IMIPRAMINE; KETOCONAZOLE; MICE; MICE, INBRED STRAINS; NIFURTIMOX; NIGERICIN; NIRIDAZOLE; PROTRIPTYLINE; TRYPANOSOMA CRUZI;

ANIMALIA; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0030734336     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-216-44192     Document Type: Article

References (21)

1. World Health Organization, Tropical Disease Research, Twelfth Programme Report of the UNDP/World Bank/WHO, Special Programme for Research and Training in Tropical Diseases (TDR). Geneva: World Health Organization, 1995.
2. McCabe RE, Remington JS. Ketoconazole inhibition of intracellular multiplication of Trypanosoma cruzi and protection of mice against lethal infection with the organism. J Infect Dis 150:594-601, 1984.
3. Brener Z, Cancado JR, Galvao LM, da Luz ZM, Filarde L de S, Pereira ME, Santos LM, Cancado CB. An experimental and clinical assay with ketoconazole in the treatment of Chagas disease. Mem Inst Oswaldo Cruz, Rio de Janeiro 88:149-153, 1993.
4. Kinnamon KE, Steck DA, Hanson WL, Chapman WL Jr. In search of anti-Trypanosoma cruzi drugs: New leads from a mouse model. Med Chem 20:741-744, 1977.
5. Thompson PE, Bayles A. Effects of triaminoquinazolines against Trypanosoma cruzi in mice. J Parasitol 56:616-617, 1970.
6. Hanson WL, Waits VB, Kinnamon KE, Poon BT. Searching for effective drugs against Chagas' disease: A look at some standards. XIVth International Congress for Tropical Medicine and Malaria, Nagasaki, Japan, 17-22 November 1996. Nagasaki: Showado Printing.
7. De Castro SL. The challenge of Chagas' disease chemotherapy: An update of drugs assayed against Trypanosoma cruzi. Acta Trop 53:83-98, 1993.
8. Baldessarini RJ. Drugs and the treatment of psychiatric disorders. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, Eds. The Pharmacological Basis of Therapeutics (9th ed). New York: McGraw-Hill, pp 431-459, 1996.
9. Hammond DJ, Cover B, Gutteridge WE. A novel series of chemical structures active in vitro against the trypomastigote form of Trypanosoma cruzi. Trans R Soc Trop Med Hyg 78:91-95, 1984.
10. Doyle PS, Weinbach EC. The activity of tricyclic antidepressant drugs against Trypanosoma cruzi. Exp Parasitol 68:230-234, 1989.
11. Schildkraut JJ. The catecholamine hypothesis of affective disorders: A review of supporting evidence. Am J Psychiatry 122:509-522, 1965.
12. Nieforth KA, Gianutsos G. Central nervous system stimulants. In: Foye WO, Lemke TL, Williams DA, Eds. Principles of Medicinal Chemistry (4th ed). Baltimore, MD: Williams & Wilkins, pp 270-294, 1995.
13. Lullmann H, Lullmann-Rauch R, Wassermann O. Lipidosis induced by amphiphilic cationic drugs. Biochem Pharmacol 27:1103-1108, 1978.
14. Kursch B, Lullmann H, Mohr K. Influence of various cationic amphiphilic drugs on the phase-transition temperatures of phosphalidylcholine liposomes. Biochem Pharmacol 32:2589-2594, 1983.
15. Zilberstein D, Dwyer DM. Antidepressants cause lethal disruption of membrane function in the human protozoan parasite Leishmania. Science 226:977-979, 1984.
16. Weinbach EC, Costa JL, Claggett CE, Morris SJ, Nelson BD, Hundal T. Effects of tricyclic antidepressants on energy-linked reactions of mitochondria and chromaffin granules. Fed Proc 42:2142, 1983.
17. Rifkin MR. Identification of the trypanocidal factor in normal serum: High density lipoprotein. Proc Natl Acad Sci USA 75:3450-3454, 1978.
18. Smith AB, Esko JD, Hajduk SL. Killing of trypanosomes by the human haptoglobin-related protein. Science 268:284-286, 1995.
19. Croft SL, Walker JJ, Gutteridge WE. Screening of drugs for rapid activity against Trypanosoma cruzi trypomastigotes in vitro. Trop Med Parasitol 19:145-148, 1988.
20. Hammond DJ, Hogg J, Gutteridge WE. Trypanosoma cruzi: Possible control of parasite transmission by blood transfusion using amphophilic cationic drugs. Exp Parasitol 60:32-42, 1985.
21. Gutteridge WE, Gaborak M, Cover B. Comparative study of SQ 18 506 with other nitroheterocyclic compounds on experimental Chagas' disease. Ann Trop Med Parasitol 72:339-347, 1978.